EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature

Jakub Wnuk iD, Joanna Katarzyna Strzelczyk iD, Iwona Gisterek iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065113 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jakub Wnuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Radiotherapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 35 Ceglana St., 40-515 Kat…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, MicroRNAs, Circulating MicroRNA. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is considered to be the seventh most common cause of cancer-related deaths. The number of deaths caused by PC is estimated to increase in the future. An early diagnosis of PC is crucial for improving treatment outcomes. The most common histopathological subtype of PC is pancreatic ductal adenocarcinoma (PDAC). MicroRNAs (miRNAs)—which are endogenous non-coding RNAs involved in the posttranscriptional regulation of multiple gene expression—constitute useful diagnostic and prognostic biomarkers in various neoplasms, including PDAC. Circulating miRNAs detected in a patient’s serum or plasma are drawing more and more attention. Hence, this review aims at evaluating the clinical value of circulating miRNA in the screening, diagnosis, prognosis and monitoring of pancreatic ductal adenocarcinoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsCarcinoma, Pancreatic DuctalMicroRNAsCirculating MicroRNAHumansBiomarkers, TumorGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

circulating miRNAdiagnosispancreatic cancerpancreatic ductal adenocarcinomaprognosisscreeningtherapy monitoring

Substanzen

Biomarkers, TumorMicroRNAsCirculating MicroRNA

Autor:innen und Institutionen

  • Department of Oncology and Radiotherapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 35 Ceglana St., 40-515 Katowice, Poland.
  • Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 19 Jordana St., 41-808 Zabrze, Poland.

ORCID-Profile: Jakub Wnuk, Joanna Katarzyna Strzelczyk, Iwona Gisterek

Förderung

  • Medical University of Silesia

Zitieren

APA

Wnuk, J., Strzelczyk, J. K., & Gisterek, I. (2023). Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065113

Vancouver

Wnuk J, Strzelczyk JK, Gisterek I. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065113

BibTeX
@article{Wnuk2023,
  author = {Wnuk, Jakub and Strzelczyk, Joanna Katarzyna and Gisterek, Iwona},
  title = {Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma–A Review of the Literature},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065113}
}
Kostenlos starten →